Leukemia Research
Volume 26, Issue 11 , Pages 1017-1025, November 2002

HL-60 cell growth-conditioned medium is an effective inducer of myeloperoxidase expression in K-562 human leukemia cells

Department of Medical Genetics, University of Tennessee, Medical Center at Knoxville, Graduate School of Medicine, Box 2, 1924 Alcoa Highway, Knoxville, TN 37920, USA

Received 20 June 2001; accepted 20 February 2002.

Abstract 

K-562 cells were cultured in HL-60 cell growth-conditioned medium (GCM) for up to 96h. Myeloperoxidase (MPO) mRNA was transiently detected by reverse transcription-polymerase chain reaction (RT-PCR) techniques at 12, 24, and 48h. The de novo expression of MPO protein was subsequently detectable by intracellular flow cytometry at 24, 48, 72 and 96h. Immunogold staining and cytochemical analysis demonstrated granularly-sequestered MPO in approximately 40% of HL-60 GCM-cultured cells after 48h of culture. The sequential detection of MPO mRNA and MPO biosynthesis is considered an indicator of serial maturation evocative of myeloblastic cells, and suggest that K-562 cells maintain the ability to differentiate along this lineage.

Abbreviations:  MPO, myeloperoxidase, MHC, major histocompatibility complex, IFN-γ, interferon-γ, PMA, phorbol 12-myristate 13-acetate, GCM, growth-conditioned medium, RT-PCR, reverse transcription-polymerase chain reaction, FBS, fetal bovine serum, TEM, transmission electron microscopy, FITC, fluoroscein isothiocyanate, PE, phycoerythrin, KLH, keyhole limpet hemocyanin, ER, endoplasmic reticulum

Keywords:  K-562 cells, Myeloperoxidase, MPO mRNA, MPO protein, Differentiation, Growth-conditioned medium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(02)00043-7

Leukemia Research
Volume 26, Issue 11 , Pages 1017-1025, November 2002